ALGRX 4975 in the Treatment of Patients With Morton's Neuroma
Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
Subjects will have painful primary or post-operative intermetatarsal neuroma. Study drug or
placebo will be injected into the space containing the neuroma. Subjects will complete weekly
assessments for severity of foot pain, a brief pain inventory, and the amount of pain
medication taken. Subjects will be seen for a screening visit, a treatment visit, and two
follow-up visits after treatment. The last scheduled visit is one month after treatment. Some
subjects may be followed by monthly telephone interviews to assess their level of pain over
the six-month period following treatment.